Medgenics Reports Open Market Purchase of Common Stock by Chairman of the Board
04 December 2013 - 12:30AM
Business Wire
Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG) (the
Company), the developer of Biopump(TM) a novel technology for the
sustained production and delivery of therapeutic proteins in
patients using their own tissue, announces that on December 2,
2013, was informed by Dr. Sol Barer, Medgenics’ Chairman of the
Board of Directors, that he purchased 20,000 shares of common stock
on the open market on that day at an average price of $6.5890 per
share.
Following this purchase, Dr. Barer now owns 92,000 shares of
common stock, which represents approximately 0.5 percent of the
total issued shares of common stock. Dr. Barer, directly or through
trusts for the benefit of Dr. Barer and his family, also has the
right to purchase up to 1,315,000 shares of common stock pursuant
to options previously granted (in aggregate Dr. Barer’s shares of
common stock and options represent 1,407,000 shares of common stock
which represent approximately 7.6 percent of the Company’s total
issued shares of common stock).
This announcement is being made pursuant to the London Stock
Exchange’s AIM Rules for Companies admitted to trading on the AIM
market.
About Medgenics
Medgenics is developing and commercializing Biopump(TM), a
proprietary tissue-based platform technology for the sustained
production and delivery of therapeutic proteins using the patient's
own tissue for the treatment of a range of chronic diseases
including anemia, hepatitis, among others. For more information,
please visit www.medgenics.com.
Medgenics, Inc.John Leaman,
CFOjohn.leaman@medgenics.comorLHAAnne Marie Fields,
212-838-3777afields@lhai.com@LHA_IR_PRorAbchurch
CommunicationsJoanne Shears / Jamie Hooper / Harriet Rae+44 207 398
7718harriet.rae@abchurch-group.comorOriel Securities (NOMAD &
Broker)Jonathan Senior / Giles Balleny+44 207 710 7617
Aevi Genomic Medicine (NASDAQ:GNMX)
Historical Stock Chart
From Sep 2024 to Oct 2024
Aevi Genomic Medicine (NASDAQ:GNMX)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about Aevi Genomic Medicine Inc (NASDAQ): 0 recent articles
More Medgenics, Inc. News Articles